FDA Inspection 1220856 — OTE Pharma Sol B.V.
The FDA completed an inspection of OTE Pharma Sol B.V. on September 15, 2023 in Uden. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 15, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Uden (Netherlands)